Orange Book product · Generic (ANDA)
BRIMONIDINE TARTRATE
BRIMONIDINE TARTRATE
At a glance
Apr 16, 2026
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 16, 2026
2 mo ago
Today
Pharmaceutical detail
Active ingredient
BRIMONIDINE TARTRATE
Strength
0.1%
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
AB
Application
ANDA 220398
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BRIMONIDINE TARTRATE
- 2024LUMIFY PRESERVATIVE FREEBrand (NDA)
NDA 218424 · BAUSCH AND LOMB INC
- 2017LUMIFYBrand (NDA)
NDA 208144 · BAUSCH AND LOMB INC
- 2013MIRVASOBrand (NDA)
NDA 204708 · GALDERMA LABS LP
- 2006QOLIANABrand (NDA)
NDA 021764 · SANDOZ
- 2005ALPHAGAN PBrand (NDA)
NDA 021770 · ABBVIE
- 2001ALPHAGAN PBrand (NDA)
NDA 021262 · ABBVIE
- 1997ALPHAGANBrand (NDA)
NDA 020490 · ALLERGAN
- 1996ALPHAGANBrand (NDA)
NDA 020613 · ALLERGAN
- 2026BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 218558 · MICRO LABS
- 2026BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 219219 · GLAND
- 2025BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 217599 · UPSHER SMITH LABS
- 2024BRIMONIDINE TARTRATEGeneric (ANDA)
ANDA 213215 · LUPIN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
